Primary results from IChoice-02, a phase 2 trial of induction chemoimmunotherapy followed by response-adapted de-escalation of chemoradiation in HPV-associated oropharyngeal cancer.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Author: Xueguan Lu
Institutions: Fudan University, Fudan University Shanghai Cancer Center
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Shanghai Junshi Biosciences
OpenAlex ID: W4410804983